Brentuximab Intravenous and Kogenate FS Bio-Set
Determining the interaction of Brentuximab Intravenous and Kogenate FS Bio-Set and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Kogenate FS recombinant
- Brentuximab Intravenous-Kola-Pectin
- Brentuximab Intravenous-Kola-Pectin DS
- Brentuximab Intravenous-Kolephrin
- Brentuximab Intravenous-Kombiglyze XR
- Brentuximab Intravenous-Kondremul
- Kogenate FS Bio-Set-Brentuximab vedotin
- Kogenate FS Bio-Set-Breo Ellipta
- Kogenate FS Bio-Set-Brethine
- Kogenate FS Bio-Set-Brethine Subcutaneous
- Kogenate FS Bio-Set-Bretylium
- Kogenate FS Bio-Set-Bretylium Injection